Feb 07, 2017 13:01 pm UTC| Business
- Phase 1 trial will evaluate Actimab-M in treating patients with multiple myeloma who are unresponsive to currently available therapies - Clinical trial initiated at Texas Oncology - Baylor Charles A. Sammons Cancer...
ABM Industries Enters into Agreement to Settle Class Action Lawsuit
Feb 07, 2017 13:01 pm UTC| Business
NEW YORK, Feb. 07, 2017 -- ABM (NYSE:ABM), a leading provider of facility solutions, today announced that on February 6, 2017, the Company entered into an agreement to settle all claims in the class action lawsuit...
Feb 07, 2017 13:01 pm UTC| Business
OKLAHOMA CITY, Feb. 07, 2017 -- Gulfport Energy Corporation (NASDAQ:GPOR) (“Gulfport” or the “Company”) today scheduled its fourth quarter and full-year 2016 financial and operational results conference call. Gulfport...
Feb 07, 2017 13:01 pm UTC| Business
AUSTIN, Texas, Feb. 07, 2017 -- SmallCapVoice.com, Inc. (SCV) and Geospatial Corporation (OTCQB:GSPH) announced today that the Company’s CEO, Mark Smith, is featured in an audio interview at Smallcapvoice.com. The...
Feb 07, 2017 13:01 pm UTC| Business
CAMBRIDGE, Mass., Feb. 07, 2017 -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will release its financial results for the...
Dimension Therapeutics Elects Dr. John A. Hohneker to Its Board of Directors
Feb 07, 2017 13:01 pm UTC| Business
CAMBRIDGE, Mass., Feb. 07, 2017 -- Dimension Therapeutics, Inc. (NASDAQ:DMTX), a biopharmaceutical company advancing novel, adeno-associated virus (AAV) gene therapies targeting the liver, a key organ for human...
Swanepoel T3 Group Adds New MLS Consulting Division
Feb 07, 2017 13:01 pm UTC| Business
SAN JUAN CAPISTRANO, Calif., Feb. 07, 2017 -- The Swanepoel T3 Group, the residential real estate industry’s premiere research and management consulting firm, has launched a new division focused on serving the multiple...